The Vivalytic analyser is a universal, fully automated all in one solution for molecular diagnostics. It is a cartridge-based platform enabling sample to answer molecular diagnostic. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. This includes the Randox Multiplex Respiratory Tract Infection Array and Sexually Transmitted Infection Array, powered by our proprietary Biochip Array Technology as well as Flu A/B and RSV. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform.

Key Benefits:

• Ease of Use
• Fully Automated
• Hi-Plex & Lo-Plex Capabilities
• Wireless Connectivity

The Evidence Investigator is a compact semi-automated benchtop analyser. It is a perfect fit for medium throughput laboratories seeking maximum use of bench space without compromising on the volume of samples processed.

• Detection from nucleic acid
• Batch testing
• Suitable for laboratory setting
• Comprehensive test menu

The Randox Discovery is an exciting and disruptive molecular & immunoassay diagnostic analyser capable of consolidating the normal workload of multiple laboratories, into one compact benchtop platform. Randox patented Biochip Technology allows simultaneous detection of hundreds of targets from a single patient sample.

The benefits of multiplexing in this way are endless; allows complete patient profiling, reduces the amount of time spent on individual tests, identifies co-infections, differentiates between pathogens that exhibit similar symptoms and eliminates the need to run multiple time consuming and sample intensive assays. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction.

Key Benefits:

• Simultaneous detection of hundreds of targets from a single patient sample via patented biochip technology
• Fully automated platform increasing operator walkaway time. A single operator is all that’s required to run up to 3 Discovery analysers
• Three hours to first batch of results with results for subsequent batches every hour after. Each batch may contain up to 16 patient samples
• Our flexible test menu comprises immunoassay and molecular diagnostic assays
• Simple and easy to use. Intuitive user interface guides the operator through the entire testing process

Qnostics range is designed to mimic the performance of patient samples and can be used to effectively monitor the performance of the entire testing process including extraction, amplification and detection.

All Qnostics controls can be described as true third party controls delivering an independent, unbiased assessment of assay performance whilst helping to meet regulatory requirements.

All samples are conveniently supplied in a liquid frozen format meaning there is no additional preparation or handling required.

The Qnostics control portfolio covers a wide range of targets including Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, STIs, Gastrointestinal Diseases, Central Nervous Diseases, Exotic Diseases and a range of products for the testing of SARS-CoV-2.

A variety of QCMD programmes are available with different challenges providing your laboratory with plenty of choice.

A variety of QCMD programmes are available with different challenges providing your laboratory with plenty of choice.

Participants will receive reports for each challenge and a final supplementary report at the end of the cycle for a visual assessment of performance.

ITEMS provide an online tool to easily manage all EQA activities from programme registration to submission of results and provision of EQA reports.

Boasting the largest selection of molecular EQA programmes for infectious disease testing, QCMD have an EQA for every laboratory’s testing requirements.